For Immediate Release

Contact:  Shawn M. Harrington

November 25, 2003

(860) 644-1551

 

GERBER SCIENTIFIC ANNOUNCES FISCAL 2004 SECOND QUARTER RESULTS

Board Votes to Recommend Declassification

 

SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported fiscal second quarter earnings of $0.12 per diluted share on revenues of $130.3 million for the period ended
October 31, 2003, compared with year-ago earnings of $0.14 per diluted share on revenues of $128.8 million.

For the six months ended October 31, 2003, the Company reported earnings of $0.14 per diluted share on revenues of $259.2 million, compared with year-ago earnings of $0.30 per diluted share on revenues of $254.7 million. Excluding a prior year sale of a discontinued operation, earnings from continuing operations for the six months ended October 31, 2002 were $0.24 per diluted share.

Foreign currency translation had the effect of increasing revenue by $8.2 million and $18.3 million for the three- and six-month periods ended October 31, 2003, respectively, versus the prior year comparable periods.

Second quarter highlights included:

Commenting on the second quarter results, Marc T. Giles, president and chief executive officer said "We did not see an upturn in our business in the second quarter and visibility is low. While I am pleased with the progress made with our turnaround initiatives, especially shared services cost reductions, competitive pricing and unfavorable sales mix outweighed the cost benefits realized to date. We remain focused on cost reduction while uncertainty in global economic conditions continues. Going forward, our strategy remains unchanged: reduce debt, improve Spandex's operations, implement shared services, and reinvigorate innovation."

Fiscal Second Quarter Consolidated Results

Fiscal second quarter revenue and order entry were $130.3 million and $131.0 million, respectively, compared with $128.8 million and $127.1 million a year ago. Foreign currency translation had the effect of increasing revenue by approximately $8.2 million in the fiscal second quarter versus the prior year comparable period.

The Company's backlog of orders increased $0.7 million during the fiscal second quarter to $32.0 million, which occurred primarily within the Apparel and Flexible Materials segment.

Fiscal second quarter gross margin of 34.4% decreased 1.2 percentage points from the prior year comparable period. Lower business volume, competitive pricing, a sales mix favoring lower margin products, and higher pension expenses were partially offset by cost reductions implemented last fiscal year.

Consolidated S,G,&A spending was lower than the prior year comparable period after adjusting for the effect of foreign currency translation. This was the result of cost reduction initiatives implemented last fiscal year, lower bonus expense, and lower legal and professional expenses. These effects were partially offset by higher pension costs.

Consolidated pension expense was approximately $0.9 million higher in the fiscal second quarter than in the prior year comparable period due primarily to changed assumptions for future pension plan investment performance and discount rates. There have been no subsequent changes to those assumptions.

Consolidated other expense included approximately $1.1 million of foreign currency transaction losses. The Company recognizes foreign currency gains and losses on the payment and translation of accounts payable balances that are reported in one currency and paid in another.

Second quarter restructuring charges of $0.5 million were the result of the transition of the Ophthalmic Lens Processing segment's operations to the Company's shared services platform and the discontinuation of an insignificant product line within the Company's Sign Making and Specialty Graphics segment.

Interest expense increased $1.1 million due to a higher weighted-average interest rate, which was partially offset by lower average debt balances. The Company's weighted average interest rate increased under the terms of the four-year $110.0 million senior credit facility entered into on May 9, 2003.

In the second quarter, the Company recorded a tax benefit of $2.2 million associated with the favorable resolution of a prior year foreign tax issue. Without the tax benefit, the Company's consolidated tax rate from continuing operations would have been 26.4% versus the statutory rate of 35.0%. The difference from the statutory rate was primarily attributable to benefits related to foreign tax planning strategies.

Fiscal Second Quarter Segment Results

Segment profit (defined as earnings before interest and taxes - see attached reconciliation to GAAP measure) for the fiscal second quarter decreased to $9.1 million from $10.8 million in the prior year comparable period.

Sign Making and Specialty Graphics

The Sign Making and Specialty Graphics segment reported revenues of $71.5 million in the fiscal second quarter, an increase of $2.6 million over the prior year comparable period. Foreign currency translation had the effect of increasing revenue by $6.4 million in the second fiscal quarter versus the prior year period. The overall decrease was the result of continued soft economic conditions for this segment's capital equipment products, particularly in Europe. Lower equipment sales in this segment's distribution business was the result of the weaker European economy, competition in inkjet imaging products, and disruption caused by the Company's re-engineering efforts.

Segment profit decreased $0.9 million versus the prior year comparable period. Lower sales volume, competitive price discounting, and higher pension expense ($0.4 million) were partially offset by cost control, lower bonus expense, and contract research and development reimbursements.

Apparel and Flexible Materials

The Apparel and Flexible Materials segment's revenues increased 1.5%, or $0.6 million, to $38.4 million in the second fiscal quarter from the comparable period last year. Foreign currency translation had the effect of increasing revenue by $1.5 million in the fiscal second quarter versus the prior year comparable period.

Segment gross margin of 45.5% decreased 2.3 percentage points from the prior year comparable period due primarily to competitive pricing, but also to the effects of lower sales volume and a sales mix favoring lower margin, multi-ply cutter products versus higher margin, single-ply cutter and software products.

Segment profit increased by $0.5 million over the prior year comparable period despite the lower volume and unfavorable product mix. This resulted from a significant cost reduction associated with the Company's shared services initiative and lower current year bonus expense. Offsetting this, second quarter pension expense was $0.3 million higher than the prior year comparable period.

Segment order entry was $39.0 million, an increase of 5.3% from the prior year and largely the result of favorable foreign currency translation effects. Backlog increased 2.1% from the beginning of the quarter to $28.5 million primarily due to the growth of equipment orders received at the end of the quarter.

Ophthalmic Lens Processing

The Ophthalmic Lens Processing segment reported revenues of $20.4 million, a decrease of $1.7 million from the second quarter of fiscal 2003. The decrease was the result of prior year equipment purchases by large U.S. retail and discount chain customers that did not repeat this year. Higher current year equipment shipments to wholesale optical laboratories were an offset. The effect of foreign currency translation on revenues was not significant.

Segment profit decreased $1.2 million over the prior year comparable period due primarily to the lower sales volume. Also contributing to the decrease were restructuring and other charges associated with the November 1, 2003 transition of segment operations to the Company's shared services and information technology system platforms. Second quarter pension expense was approximately $0.1 million higher than the prior year comparable period in this segment. These unfavorable variances were partially offset by lower bonus expense.

Corporate and Other Expenses

Corporate and other expenses increased to $5.1 million from $4.2 million in the prior year comparable period. Higher pension and insurance costs, as well as foreign currency transaction losses, were partially offset by lower legal and professional expenses and lower bonus expense.

Financial Condition

For the six months ended October 31, 2003, total debt was reduced by $5.2 million, which was the result of operating earnings, reduced cash balances, reduced capital expenditures, and proceeds from the sale of a promissory note in the first quarter.

At October 31, 2003, the Company had $9.7 million in cash and cash equivalents and $80.6 million in total debt. The Company's net debt (defined as total debt less cash and cash equivalents) declined $7.9 million during the second quarter to $71.0 million and the ratio of net debt to capital (defined as the sum of net debt and shareholders' equity) was 40.3%.

The Company was in compliance with all covenants related to its credit facilities as of October 31, 2003. Continued uncertainty in global economic conditions and prolonged weak business environments continue to make estimating demand for the Company's capital equipment products and projecting future results challenging. Although the Company continues to closely monitor compliance with covenants under its credit facilities, failure to be in compliance with any material covenant of the credit facilities could have a material effect on the Company's liquidity, financial position, and results of operations.

Recommendation to Eliminate Classified Board

Upon recommendation of the Nominating and Governance Committee, the Board of Directors unanimously voted to recommend to shareholders for a vote at the Company's 2004 annual meeting charter and bylaw amendments to eliminate the Board's classified structure. If this recommendation should be adopted by at least 80% of the outstanding shares entitled to vote at the Company's 2004 annual meeting, all directors would stand for election or re-election each year beginning at the Company's 2005 annual meeting.

About Gerber Scientific, Inc.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is the world's leading supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products and Spandex Ltd., Gerber Technology, and Gerber Coburn.

Safe Harbor Statement:

In addition to the historical information contained herein, there are matters discussed that are considered to be "forward-looking statements." The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. These forward-looking statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, and services, that could significantly affect results in the future. For a discussion of other risk factors relating to the Company's business, see the Company's Quarterly Report on Form 10-Q for the quarter ended July 31, 2003 and its Annual Report on Form 10-K for the year ended April 30, 2003, as filed with the Securities and Exchange Commission. The forward-looking statements contained in this release are made as of the date of this release, and the Company assumes no obligation to update or revise any forward-looking statements contained in this release.

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS


(Unaudited)

Three Months Ended
October 31,

Six Months Ended
October 31,

             

In thousands (except per share amounts)

2003 

 

2002 

2003 

 

2002 

             

Revenue:

           

     Product sales

$115,747 

 

$114,869 

$230,436 

 

$227,096 

     Service sales

  14,538 

 

  13,911 

  28,806 

 

   27,562 

130,285 

128,780 

259,242 

 254,658 

Costs and Expenses:

           

     Cost of products sold

77,701 

 

75,799 

155,336 

 

150,613 

     Cost of services sold

7,820 

 

7,145 

15,314 

 

14,337 

     Selling, general and administrative

32,714 

 

32,417 

65,747 

 

64,130 

     Research and development

6,435 

 

6,516 

12,626 

 

12,792 

     Restructuring charges

       486 

 

        ---  

       486 

 

     (100)

 

125,156 

 

121,877 

249,509 

 

241,772 

Operating income

5,129 

 

6,903 

9,733 

 

12,886  

             

Other income (expense)

(1,137)

 

(340)

(2,153)

 

(1,206)

Interest expense

   (3,212)

 

   (2,146)

   (6,315)

 

   (4,377)

Earnings from continuing operations before
     income taxes


780 

 


4,417 


1,265 

 


7,303 

Provision (benefit) for income taxes

   (1,982)

 

     1,300 

   (1,860)

 

    1,964 

Earnings from continuing operations

2,762 

 

3,117 

3,125 

 

5,339 

Discontinued operations:

           

     Income from operations of disposed
         business, net of tax


--- 

 


--- 


--- 

 


172 

     Gain on sale of disposed business, net of tax

          --- 

 

          --- 

         --- 

 

     1,222 

Net earnings

$   2,762 

 

$   3,117 

$   3,125

 

$   6,733 

 

=======

 

=======

=======

 

=======

Earnings per share of common stock:

           

Basic:

           

     Earnings from continuing operations

$       .12 

 

$       .14 

$       .14 

 

$       .24 

     Discontinued operations

         ---  

 

         ---  

         ---  

 

         .06 

     Net earnings

$       .12 

 

$       .14 

$       .14 

 

$       .30 

 

=======

 

=======

=======

 

=======

             

Diluted:

           

     Earnings from continuing operations

$       .12 

 

$       .14 

$       .14 

 

$       .24 

     Discontinued operations

         ---  

 

         ---  

         ---  

 

        .06 

     Net earnings

$       .12 

 

$       .14 

$       .14 

 

$       .30 

 

=======

 

=======

=======

 

=======

             

     Dividends

$        ---  

 

$        ---  

$        ---  

 

$        --- 

Average shares outstanding:

           

     Basic

22,193 

 

22,137 

22,183 

 

22,123 

     Diluted

22,455 

 

22,137 

22,464 

 

22,123 

 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

(Unaudited)


In thousands (except per share amounts)

October 31, 2003

 

April 30, 2003

Assets:

     

Current Assets:

     

     Cash and cash equivalents

$   9,680 

 

$   20,697 

     Accounts receivable, net of allowance for doubtful
        accounts of $8,251 and $7,277, respectively


89,938 

 


89,657 

     Inventories

52,736 

 

51,982 

     Deferred income taxes

3,855 

 

5,300 

     Prepaid expenses and other current assets

  10,330 

 

    8,327 

 

166,539 

 

175,963 

Property, Plant and Equipment:

122,368 

 

122,674 

     Less accumulated depreciation

  77,614 

 

  75,309 

 

  44,754 

 

  47,365 

Intangible Assets:

     

     Goodwill

50,231 

 

    48,912 

     Prepaid pension cost

8,483 

 

    8,483 

     Patents and other intangible assets, net of accumulated         amortization


    6,718 

 


    6,777 

 

  65,432 

 

  64,172 

Deferred Income Taxes

17,779 

 

14,855 

Other Assets

    8,913 

 

    4,336 

 

$303,417 

 

$306,691 

 

======

 

======

Liabilities and Shareholders' Equity:

     

Current Liabilities:

     

     Current maturities of long-term debt

$   10,941 

 

$   14,807 

     Accounts payable

39,917 

 

45,024 

     Accrued compensation and benefits

13,766 

 

23,167 

     Other accrued liabilities

22,646 

 

18,202 

     Deferred revenue

11,153 

 

10,000 

     Advances on sales contracts

   1,045 

 

       945 

 

 99,468 

 

112,145 

Noncurrent Liabilities:

     

     Accrued pension benefit liability

23,549 

 

23,549 

     Other liabilities

5,517 

 

5,534 

     Long-term debt

  69,704 

 

  71,000 

 

  98,770 

 

 100,083 

 

Contingencies and Commitments:

     

Shareholders' Equity:

     

     Preferred stock, no par value; authorized 10,000,000          shares; no shares issued


--- 

 


--- 

     Common stock, $1.00 par value; authorized 65,000,000          shares; issued 22,933,421 and 22,908,180 shares


 22,933 

 


 22,908 

     Paid-in capital

 43,624 

 

 43,703 

     Retained earnings

 71,037 

 

 67,912 

     Treasury stock, at cost (730,635 and 745,184 shares,          respectively)


(15,024)

 


(15,323)

     Unamortized value of restricted stock grants

(151)

 

(211)

     Accumulated other comprehensive loss

(17,240)

 

 (24,526)

 

105,179 

 

  94,463 

 

$303,417 

 

$306,691 

 

======

 

======

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS


(Unaudited)

Six Months Ended
October 31,

In thousands

2003 

 

2002 

Cash Provided by (Used for):

Operating Activities:

     

     Net earnings

$   3,125 

 

$   6,733 

     Adjustments to reconcile net earnings
        to cash provided by (used for) operating activities:

     

           Depreciation and amortization

5,926 

 

6,751 

           Restructuring charges

486 

 

(100)

           Gain on sale of disposed business, net of taxes

---  

 

(1,222)

           Deferred income taxes

(1,855)

 

289 

           Other non-cash items

1,370 

 

550 

     Changes in operating accounts:

     

           Receivables

1,101 

 

1,360 

           Inventories

677 

 

(380)

           Prepaid expenses

(1,520)

 

2,903 

           Accounts payable and accrued liabilities

   (9,671)

 

   (4,198)

Provided by (Used for) Operating Activities:

      (361)

 

   12,686 

Investing Activities:

     

     Additions to property, plant and equipment

(1,654)

 

(900)

     Intangible and other assets

(567)

 

(480)

     Proceeds from sale of assets

---  

 

3,937 

     Proceeds from sale of disposed business

---  

 

6,595 

     Proceeds from settlement of promissory note

        994 

         --- 

Provided by (Used for) Investing Activities:

   (1,227)

 

    9,152 

Financing Activities:

     

     Additions of long-term debt

170,826 

 

3,000 

     Repayments of long-term debt

(175,988)

 

(16,673)

     Net short-term financing

    ---  

 

    (205)

     Debt issue costs

(5,604)

 

(376)

     Exercise of stock options

71 

 

--- 

     Other common stock activity

          44 

 

          53 

(Used for) Financing Activities:

 (10,651)

 

 (14,201)

Effect of exchange rate changes on cash

1,222 

889 

Increase (Decrease) in Cash and Cash
    Equivalents


(11,017)

 


8,526 

Cash and Cash Equivalents, Beginning of Period

   20,697 

 

  16,220 

Cash and Cash Equivalents, End of Period

$   9,680 

 

$ 24,746 

====== 

====== 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
SEGMENT INFORMATION

(Unaudited)

   


In thousands

Three Months Ended
        October 31,       

Six Months Ended
October 31,

         

Segment revenue:

    2003   

    2002   

    2003   

    2002   

Sign Making & Specialty Graphics

$  71,472 

$  68,872 

$144,313 

$135,266 

Apparel & Flexible Materials

38,378 

37,806 

75,985 

76,484 

Ophthalmic Lens Processing

   20,435 

   22,102 

   38,944 

   42,908 

 

$130,285 

$128,780 

$259,242 

$254,658 

 

=======

=======

=======

=======

         

Segment profit:

       

Sign Making & Specialty Graphics

$    4,509 

$    5,431 

$    9,578 

$    9,920 

Apparel & Flexible Materials

4,178 

3,712 

7,151 

7,706 

Ophthalmic Lens Processing

        392 

     1,626 

        351 

     2,707 

 

9,079 

10,769 

17,080 

20,333 

Corporate expenses, net of other      income


(5,087)


(4,206)


(9,500)


(8,653)

Interest expense

    (3,212)

    (2,146)

    (6,315)

    (4,377)

Earnings from continuing
     operations before income taxes


$       780 


$    4,417 


$    1,265 


$    7,303 

 

=======

=======

=======

=======

         

Segment profit for the six-month period ended October 31, 2002 included a reversal of previously established restructuring reserves of $100 for the Apparel and Flexible Materials operating segment.

Segment profit for the three and six months ended October 31, 2003 included restructuring charges of $172 for the Sign Making and Specialty Graphics operating segment and $314 for the Ophthalmic Lens Processing operating segment.